Publication Details

AFRICAN RESEARCH NEXUS

SHINING A SPOTLIGHT ON AFRICAN RESEARCH

medicine

Off-label use of bedaquiline in children and adolescents with multidrug-resistant tuberculosis

Emerging Infectious Diseases, Volume 23, No. 10, Year 2017

We describe 27 children and adolescents <18 years of age who received bedaquiline during treatment for multidrug-resistant tuberculosis. We report good treatment responses and no cessation attributable to adverse effects. Bedaquiline could be considered for use with this age group for multidrug-resistant tuberculosis when treatment options are limited. © 2017, Centers for Disease Control and Prevention (CDC). All rights reserved.
Statistics
Citations: 43
Authors: 9
Affiliations: 4
Identifiers
Research Areas
Maternal And Child Health